chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 24 hrs of the injections, I noticed the color in my daughter's face change and a darkness under her eyes.  I didn't think much of it, knowing that vaccinations often challenge the immune system and cause an internal battle.  However, over the following months, I noticed that the color in her face didn't improve.  It worsened until she had dark circles under her eyes.  She began to complain of stomach aches and fatigue.  Over time, she was diagnosed with Type 1 Diabetes.  My daughter was in perfect health before this set of immunizations.  I witnessed her health decline with these immunizations.
Patient stated she was feeling woozie and didn't take her medication for her BP today. BP taken 1) 177/118  101 pulse at 12:50  2) 158/116  pulse 102 at 1:00 pm   3) 163/118  pulse 100   4) 156/109 pulse 95 at 2:06. Patient was given water. Patient stated she was felt fine; however observation continue and encourage  to take mediation BP at home.
Noted haziness in left eye and floater 11 days after shot I wear prescription glasses and  I noticed a difference in terms of my vision both near and far. I ignored at first but it got worse. I was due for my annual Ophthalmologist eye exam in mid January and they did the  visual exam That looks behind the eyes. it was noted that o had CEBTEAL RETINAL VEIN OCCLUSION . I was emergnetly referred to. a retinal Specialist that same day and he injected my eye with AVASTIN. after one month, another visual exam was  done and marked improvement was noted but I still had hazy vision despite corrective lenses and Ithat annoying floater seems to be permanent. I will see retinal Specialist again in 2 weeks.
Fatigue; Reddish urine; Body aches; This spontaneous case was reported by a physician and describes the occurrence of CHROMATURIA (Reddish urine), MYALGIA (Body aches) and FATIGUE (Fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced MYALGIA (Body aches). On 30-Mar-2021, the patient experienced CHROMATURIA (Reddish urine). On an unknown date, the patient experienced FATIGUE (Fatigue). On 02-Mar-2021, MYALGIA (Body aches) had resolved. At the time of the report, CHROMATURIA (Reddish urine) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
parents deny any rxn following vax;no signs of fever, irritability or neurologic problems;died suddenly @ 12:49PM on 20AUG96;COD SIDS:
Babysitter called. Reports (L) thigh red, knot, and warm. Encouraged to have Mom or Dad call. Public Health with concerns. Mom called reports knot, warm, slightly red. Denies any fever or concerns for child. Mom is a nurse feels babysitter is over reacting. Mother encouraged to call if any s/s worsen or requires medical intervention.
2wk p/vax devel a rash & low grade fever;fever inc to 103.6 & devel hives;was given motrin in hosp & began swelling;seen by allergist who stated allergy to nitrates in MMR vax;still breaks out @ times especially when excited, etc;
Left arm between shoulder and elbow has become very weak and painful. It is difficult to raise my left arm (or extend it to close a car door for example).
This spontaneous report was received from a registered nurse and refers to an unspecified 18-month-old patient. The patient's pertinent medical history, drug reactions and allergies were not reported. Concomitant therapies were not provided. On an unknown date, the patient was vaccinated with ROTATEQ, drug of administration was reported as injection (dose, anatomical location, lot# and expiration date were not reported), that was intended for another patient. No adverse effects were reported.
This spontaneous report as received from an unspecified reporter via representative and other company representative, refers to a 53 year old female patient. The patient's medical history and concurrent conditions were not reported. On 12-MAR-2013, the patient was vaccinated with a dose of ZOSTAVAX lot # H020683, expiration date 15-FEB-2014 via subcutaneous route (dose was not reported). No concomitant medications were reported. On an unknown date (reported as shortly afterwards), the patient developed shingles with symptoms of redness under her temple (reported as under her hairline), in the corner of her eye (unspecified) and under her nose. The patient had also a dull headache. It was reported that the patient was treated with Acyclovir over a two day period (unspecified dates). The patient was also seen by an unspecified eye doctor on an unspecified date. At the time of the report, the outcome of herpes zoster was unknown. No product quality complaint was involved. Additional information is not expected as there is no reporter contact information.
Patient reports she has had pain in the left arm around the injection site since the day after she received the vaccine.  We are now one month post-vaccination, so this is an unexpected adverse event.  She reports that the pain sometimes radiates down her arm.
LETHARGIC; CHILLS; FEVER; FELT WEAK; TIREDNESS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced lethargic, chills, fever, felt weak, and tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lethargic, chills, fever, felt weak, and tiredness. This report was non-serious.
pt afeb, generalized sz/status epilepticus 10 days p/vax w/cephalocaudal papular rash;tx w/anti sz med x 5 days;adm to hosp from ER;
Persistent URI, bruising - pancytopenia requiring platelet and red cell transfusion and stem cell boost of prior stem cell graft.
RA at deltoid, swollen, red, itching, pain and warm to the touch.
Redness L- 12 cm W-10cm warm to touch. Soreness of upper right arm.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication.   On 10-OCT-2017 the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (dose, route, lot# and expiration date were unknown) by a pharmacist for the long-term prevention of shingles and/or zoster-related conditions (for prophylaxis). Subsequent to inoculation, the patient was treated for shingles.  As a direct and proximate result of patient's use of the zoster vaccine live(ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.  Additional information has been requested.
rashy at injection sitewent down almost to the elbow (stayed for 4 days, itchy at the site)/arm was red and rashy to her elbow; rashy at injection sitewent down almost to the elbow (stayed for 4 days, itchy at the site)/arm was red and rashy to her elbow; The injection site was swollen and hot, there was redness all the way down to her elbow, and it itched; The injection site was swollen and hot, there was redness all the way down to her elbow, and it itched; The injection site was swollen and hot, there was redness all the way down to her elbow, and it itched; She was very tired; had a headache all day long that was real bad; had muscle pain at the joints; joint pain; she still shook; she felt her head and it was hot; she had nausea and had to take a pan with her to the bathroom in case she vomited; She was dizzy; Her bowels were cleaned out, it wasn't watery but it was complete- she went about 3 times; she was not feeling well; still weak; wind pipe was mucosy/her wind pipe she felt like a big lump of phlegm; Her heart was having fast heartbeats that day; body aches and pains; chills; fever; loose stools; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer patient of unknown age reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 04Feb2021 as dose 1, single for COVID-19 immunization. The medical history of the patient included strokes. She stated later her daughter-in-law, son, and granddaughter came down with covid but the caller and her son were negative. She stated she even slept with her granddaughter during that time. They tested 7 days later and were still negative. The concomitant medications were not reported. On an unknown date the post vaccination patient had all the side effects. The injection site was swollen and hot, there was redness all the way down to her elbow, and it itched. She was very tired, had a headache all day long that was real bad, had muscle pain at the joints, joint pain, and chills all day long. Even with a blanket over her and thick pants, socks, and shoes she still shook. She did not take her temperature but she felt her head and it was hot, she had nausea and had to take a pan with her to the bathroom in case she vomited. She was dizzy when she got up to bathroom. Her bowels were cleaned out, it was not watery but it was complete- she went about 3 times. She does not know about her lymph nodes but she was not feeling well. She went from the couch to the bed at 10:00 to sleep and got up the next morning and was okay but still weak. She stated over her windpipe she felt like a big lump of phlegm. Her heart was having fast heartbeats that day. She asked if she should she go back for the second dose of the vaccine given all of these symptoms. The event outcome was unknown.   No follow-up attempts were possible, information about lot/batch number could not be obtained.
Chicken pox outbreak on body on 3/20/2021 a slow and steady rate of pox popping up for a few days , the first few appeared on my face ,hairline and chest . Went to the urgent care and was diagnosed with the chicken pox was given Valacyclovir , Hydrocortisone  and a topical ointment.  Received a steriod shot to help with itching on 3/22/21 was advised to isolate until cleared .
Pt devel hives and injection site warmth, redness, and swelling following vaccination with pneumococcal vaccine.
Headache, fatigue, chills - onset 12hr after vaccination - lasted for 12hr (resolved ~24hr from vaccination).
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. The patient's concurrent condition, medical history and concomitant medication were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (route and site of administration, lot#, expiry date were not reported). On an unknown date, the patient developed shingles in the eye region and on her face after receiving ZOSTAVAX. The outcome of the event was unknown. The relatedness between the event and ZOSTAVAX was not provided. Additional information is not expected, as reporter did not wish to be contacted.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown demographics. No concurrent conditions or medical history were provided. On an unknown date, those patients were vaccinated with single doses of MMR II injection (strength, dose, route of administration, lot# and expiry date unspecified), post both supported and not supported temperature excursions. No concomitant medications were not reported. No patient had reporting experiencing an adverse effect due to receipt of vaccination post temperature excursion. This is one of several reports from the same source. Additional information has been requested.
I am feeling very anxious/I have anxiety; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (I am feeling very anxious/I have anxiety) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (I am feeling very anxious/I have anxiety). At the time of the report, ANXIETY (I am feeling very anxious/I have anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.  Company Comment: Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
HEART ISSUES; This spontaneous report received from a pharmacist concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 14-MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 14-MAY-2021, the subject experienced heart issues. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from heart issues. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not needed as per standard procedure since case is assessed as non-serious.
Patient reported right arm swelling and induration with redness and fever to 102F. Patient also had increase in WBC to 17,000 thou/mm3.
Patient complained of progressive arm pain in the arm that recieved the vaccine. Pain has been ongoing since March, patient first reported to pharmacy on 8/6/21. States that pain radiates down arm and up through shoulder and neck, says he has a hard time raising it to wash his hair. Asked patient if he had taken anything for pain, he sated that he did take Aleve the other night and that helped somewhat and he was able to sleep better. Patient has an appointment with ortho for evaluation.
Shortness of breath, migraine, Chest pain, abdominal pain, body aches, joint aches, fatigue and fever
Patient began to get pale, lightheaded and dizzy about 3 minutes after injection - pharmacist applied two ice packs to patients neck area and patient felt better with color returning and dizziness going away about 10 minutes later.  Pharmacist followed up with mother at home via phone and confirmed that patient was fine about two hours after vaccination.
Rec'd vaccine @ 6:15pm - by 6:25 p.m. exhibited facial redness, mild edema @ lips, hives on torso. Vital signs stable - BP 100/60, P 100, T 99.9, R 20. Placed in sitting position - 25 mg BENADRYL administered IM @ 6:35 pm. Breath sounds clear - equal throughout. No resp. distress @ anytime. VS remain stable. Pt observed x 1 hr after. Site MD present. Parents instructed to administer PO BENADRYL in 6 hrs.
viral encephalitis; infection in the central nervous system; deep vein thrombosis; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 47 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ENCEPHALITIS VIRAL (non-serious), outcome "unknown", described as "viral encephalitis"; CENTRAL NERVOUS SYSTEM INFECTION (non-serious), outcome "unknown", described as "infection in the central nervous system"; DEEP VEIN THROMBOSIS (non-serious), outcome "unknown", described as "deep vein thrombosis".  Clinical course: Patient does not wish to provide more information about reaction.  The lot number for bnt162b2 was not provided and will be requested during follow up.
2 adjuvants were mixed together, not administered; This case was reported by a pharmacist via call center representative and described the occurrence of intercepted product preparation error in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced intercepted product preparation error. On an unknown date, the outcome of the intercepted product preparation error was unknown.       Additional Information: GSK Receipt Date: 11-JAN-2023 Reporter's Comment: The pharmacist stated that 2 vials of the Shingrix adjuvant were mixed together instead of with the antigen. The reporter wanted to know an alternative diluent be used to reconstitute the remaining Shingrix antigen. The reporter confirmed that patient had not received the combined mixed adjuvants and that they had not reconstituted the antigen with a different diluent not supplied with vaccine.  The reporter filing for a potential medication error. The reporter decided to file the AE after the call was completed so no additional information available. Additional supportive information: The 2 vials of the Shingrix adjuvant were mixed together instead of with the antigen, which led to intercepted product preparation error.
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced headache, weakness, shivers and feeling unwell. On an unknown date, the outcome of the headache, weakness, shivers and feeling unwell were recovered/resolved. It was unknown if the reporter considered the headache, weakness, shivers and feeling unwell to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient was over 50 years old. The coworker of the reporter's husband felt sick for 2 days after getting SHINGRIX. She was unable to get up for 2 days after receiving 2nd dose. She had a severe headache along with shivering and weakness. This case has been linked with case US2018158113 and US2018158115, reported by same reporter.
4th dose received at 14 months; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 14-month-old male patient who received DTPa (Infanrix) (batch number 7C9NJ) for prophylaxis.   Previously administered products included Infanrix (patient was 6 months old when they started vaccine).   On 19-APR-2023, the patient received the 4th dose of Infanrix. On 19-APR-2023, an unknown time after receiving Infanrix, the patient experienced drug dose administration interval too short (Verbatim: 4th dose received at 14 months). The outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 19-Apr-2023 The medical assistant called on behalf of the patient.  The reporter reported that the patient received Infanrix dose early.  The reporter reported that the patient received 4th dose Infanrix.  The reporter reported that the patient was 6 months old when they started vaccine, so 4th dose was supposed to be administered at 16 to 18 months, but patient received at 14 months (current age).  The reporter consented to follow up. The patient received 4th dose of Infanrix, earlier than the recommended interval, which led to shortening of vaccinations schedule.
pt recvd vax; weakness, v, possible sz; 13oct pt unresponsive;comatose adm to hosp;dx w/devastating encephalopathy;as of 12oct in rehab hosp;
Patient reported to me today that her right arm is in pain.  No redness, no streaks, no swelling.  She has been to her PCP and was prescribed prednisone 20mg daily for 4 days on 10-29-21, then 2 more tabs on 11-1-21. Went to after hours care and got a third script for prednisone 20mg once daily for 5 days on 11-5-21. She is now taking ibuprofen and using heat 3 times daily on her arm.  She is still in pain, radiates down her arm from shoulder to elbow.
Pt went to stand up right after receiving the vaccine and immediately passed out on the floor. Upon examining the pt, pt stated she was dizzy after receiving the vaccine and we thought she just stood up too fast. Observed pt for several minutes, pt vomited shortly after and remained dizzy and sweaty. After about 30 minutes, pt stated she felt better and wanted to go on to work. While walking down the hallway to leave, pt passed out again. Contacted 911, pt had blurred vision, dizziness, slurred speech. Ambulance arrived, BP and HR were normal, but pt couldn't stand up unassisted. Pt was taken to the ER by ambulance.
This case involves a patient (unknown age and gender) who was sick (illness) after receiving INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT]. It was unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number and expiry date not reported) via unknown route in unknown administration site prophylactic vaccination. On an unknown date, the patient was sick (illness, non-serious) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. It was reported "I got mine last week and I am still sick". It was unknown if the patient experienced any additional symptoms/events. It was unknown if there were lab data/results available. It was not reported if the patient received a corrective treatment. At time of reporting, the outcome was unknown for the reported event. There will be no information available on the batch number for this case.
Appreciate 4 day after 1st Pfizer Vaccination dose. Approximately 1:00AM was awoke with a sudden Buzzing in my head. After 15 minutes or so. It changes to a very pronounced ringing. I roughed it out to see if it would subside.  By morning the squeal noise was still very strong.  After 24 hours it changed to a constant ring like tinnitus.  This is still going on to this day. Somewhat Lower in volume.      Never had this ever in my life until Vaccination.
lt arm red-swollen from elbow to & including shoulder;warm to touch;no limited ROM;pt not c/o pain or discomfort-only itching;
MMR vaccine administered 5/5/14 -> 5/16/14 presented to MD for staring spells -> now w/ epilepsy dx (Doose syndrome) and developmental regression/delays. Unknown if correlation.